Cefprozil hydrate

CAS No. 121123-17-9

Cefprozil hydrate( Cefprozil hydrate )

Catalog No. M10789 CAS No. 121123-17-9

Cefprozil hydrate (Cefzil) is a second-generation cephalosporin type antibiotic.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
10MG 35 In Stock
25MG 48 In Stock
50MG 65 In Stock
100MG 96 In Stock
200MG 138 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Cefprozil hydrate
  • Note
    Research use only, not for human use.
  • Brief Description
    Cefprozil hydrate (Cefzil) is a second-generation cephalosporin type antibiotic.
  • Description
    Cefprozil hydrate (Cefzil) is a second-generation cephalosporin type antibiotic.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Cefprozil hydrate
  • Pathway
    GPCR/G Protein
  • Target
    Antibacterial
  • Recptor
    PBPs
  • Research Area
    Infection
  • Indication
    ——

Chemical Information

  • CAS Number
    121123-17-9
  • Formula Weight
    407.44
  • Molecular Formula
    C18H21N3O6S
  • Purity
    >98% (HPLC)
  • Solubility
    Soluble in water
  • SMILES
    O=C(C(N12)=C(/C=C/C)CS[C@]2([H])[C@H](NC([C@H](N)C3=CC=C(O)C=C3)=O)C1=O)O.[H]O[H]
  • Chemical Name
    (6R,7R)-7-[[(2R)-2-Amino-2-(4-hydroxyphenyl)acetyl]amino]-8-oxo-3-[(E)-prop-1-enyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid hydrate

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Nagai K, et al . Antimicrob Agents Chemother. 2002 May;46(5):1273-80.
molnova catalog
related products
  • VB-82252

    VB-82252 is a highly potent, orally active inhibitor of C. difficile toxins TcdA and TcdB, potently inhibits UDP glucose hydrolysis activity of TcdB (IC50=32 nM).

  • Ribocil-C

    A highly selective inhibitor of the FMN riboswitch that controls expression of de novo riboflavin (Vitamin B2) biosynthesis in Escherichia coli.

  • Loganetin

    Loganetin, a non-toxic natural product, shows antibacterial activity against multidrug-resistant Gram-negative infections.